专题：Pharmaceutical Economics and Policy

This cluster of papers explores the economics of pharmaceutical research and development, focusing on topics such as drug development costs, generic drugs, pharmaceutical innovation, medicine prices, patent expiry, healthcare policies, market size, availability of medicines, and generic substitution.
最新文献
The UK government must publish a detailed impact assessment of the costs and benefits of the US-UK medicines partnership

article Full Text OpenAlex

‘Most Favored Nation’ Drug Pricing Is An Idea Whose Time Has Come

article Full Text OpenAlex

Impact of the methylphenidate shortage on the dispensing of medicines for Attention Deficit Hyperactivity Disorder in Australia: A nationwide cohort study

article Full Text OpenAlex

The European Medicines Agency (EMA)

book-chapter Full Text OpenAlex

Arzneiverordnungs-Report 2025

book Full Text OpenAlex

General Considerations for Pediatric Formulation Development: Setting Target Product Profiles

book-chapter Full Text OpenAlex

US and Moderna: FDA refuses approval process for new mRNA flu vaccine

article Full Text OpenAlex

The African Medicines Agency: historical perspective of its origins, evolution, institutional structure and future prospects

article Full Text OpenAlex

A Five-Year Trend Analysis of USFDA Expedited Approvals and Designations for New Drug Applications (2020–2024)

article Full Text OpenAlex

Health Care Plan Aims to Lower US Drug Costs and Increase Transparency

article Full Text OpenAlex

近5年高被引文献
Indian Journal of Pharmaceutical Education and Research

paratext Full Text OpenAlex 357 FWCI0

World Health Organization model list of essential medicines for children 8th list, 2021

article Full Text OpenAlex 337 FWCI119.8761

Vaccines safety case studies

book-chapter Full Text OpenAlex 332 FWCI93.9108

Improving data on pharmaceutical expenditure in hospitals and other health care settings

report Full Text OpenAlex 254 FWCI0

Navigating financial toxicity in patients with cancer: A multidisciplinary management approach

review Full Text OpenAlex 247 FWCI64.215

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

article Full Text OpenAlex 246 FWCI76.7626

Drug repurposing: a systematic review on root causes, barriers and facilitators

review Full Text OpenAlex 242 FWCI58.3773

Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations

article Full Text OpenAlex 222 FWCI60.0398

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

article Full Text OpenAlex 211 FWCI56.492

Introduction to drug utilization research

other Full Text OpenAlex 209 FWCI0